The new recently described provisional lymphoma category Burkitt-like lymphoma with 11q aberration comprises cases similar to Burkitt lymphoma (BL) on morphological, immunophenotypic and gene-expression levels but lacking the IG- translocation. They are characterized by a peculiar imbalance pattern on chromosome 11, but the landscape of mutations is not yet described. Thus, we investigated 15 -negative Burkitt-like lymphoma with 11q aberration (mnBLL,11q,) cases by copy-number analysis and whole-exome sequencing. We refined the regions of 11q imbalance and identified the INO80 complex-associated gene as a positional candidate in 11q24.3. Next to recurrent gains in 12q13.11-q24.32 and 7q34-qter as well as losses in 13q32.3-q34, we identified 47 genes recurrently affected by protein-changing mutations (each ≥3 of 15 cases). Strikingly, we did not detect recurrent mutations in genes of the ID3-TCF3 axis or the SWI/SNF complex that are frequently altered in BL, or in genes frequently mutated in germinal center-derived B-cell lymphomas like or An exception is , which was mutated in 7 of 15 cases. We conclude that the genomic landscape of mnBLL,11q, differs from that of BL both at the chromosomal and mutational levels. Our findings implicate that mnBLL,11q, is a lymphoma category distinct from BL at the molecular level.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396176PMC
http://dx.doi.org/10.1182/blood-2018-07-864025DOI Listing

Publication Analysis

Top Keywords

burkitt-like lymphoma
12
lymphoma 11q
12
11q aberration
12
burkitt lymphoma
8
lymphoma category
8
lymphoma
7
mutational landscape
4
landscape burkitt-like
4
11q
4
aberration distinct
4

Similar Publications

Various aggressive lymphomas entities have been associated with immunodeficiency. To provide further evidence that also MYC-negative high-grade B-cell (formerly Burkitt-like) lymphoma with 11q aberrations comprises an immunodeficiency-related subtype, we here conducted a comprehensive pathological and genetic workup of a 25-year-old patient with this type of lymphoma and simultaneous papillary renal cell carcinoma. The patient developed both malignancies following extensive childhood immunosuppression and a kidney transplant.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on primary lymphoid neoplasms in the urinary tract and male genital organs, which are rare and make up less than 5% of extranodal lymphomas.
  • Researchers analyzed cases diagnosed from 2005 to 2020, examining pathology slides from 11 patients, predominantly middle-aged, finding a female predominance in urinary bladder and ureter lymphomas.
  • The findings confirm that diffuse large B-cell lymphoma (DLBCL) is the most common subtype, but emphasize the importance of thorough classification and diagnosis using techniques like immunohistochemistry to accurately identify various lymphoma types.
View Article and Find Full Text PDF
Article Synopsis
  • - The study examines angioimmunoblastic T-cell lymphoma (AITL) cases with a focus on their clinical, pathological, and immunophenotypic characteristics, as well as the differential diagnosis involving B-cell proliferation or neoplasms.
  • - Eight cases from a hospital in China were analyzed, revealing one case of AITL with diffuse large B-cell lymphoma (DLBCL) and seven cases of AITL with B-cell proliferation, with an average patient age of 58 years.
  • - The findings highlight distinct histological features and tumor behavior in AITL with B-cell involvement, suggesting that a combination of clinical, morphological, and molecular analyses is essential for accurate diagnosis.
View Article and Find Full Text PDF
Article Synopsis
  • Monomorphic post-transplant lymphoproliferative disorder (mPTLD) is a significant health risk after solid organ transplants, with challenges in balancing treatment intensity and risks like infection and organ rejection.* -
  • A study analyzed 56 children with mPTLD treated with low-intensity therapies in the UK and Spain, finding that 92.8% survived for one year, despite 78.6% presenting with advanced disease.* -
  • The results indicate that R-COP, a low-dose chemotherapy, is an effective initial treatment, with escalation to more aggressive approaches beneficial for those who do not adequately respond.*
View Article and Find Full Text PDF

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.

PLoS Pathog

April 2024

Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisconsin, United States of America.

Epstein-Barr virus (EBV) is an important cause of human lymphomas, including Burkitt lymphoma (BL). EBV+ BLs are driven by Myc translocation and have stringent forms of viral latency that do not express either of the two major EBV oncoproteins, EBNA2 (which mimics Notch signaling) and LMP1 (which activates NF-κB signaling). Suppression of Myc-induced apoptosis, often through mutation of the TP53 (p53) gene or inhibition of pro-apoptotic BCL2L11 (BIM) gene expression, is required for development of Myc-driven BLs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!